Randomized phase II cancer clinical trials

DOI10.1201/B14751zbMATH Open1273.62020OpenAlexW2899031887MaRDI QIDQ2852232

Sin-Ho Jung

Publication date: 8 October 2013

Published in: Chapman \& Hall CRC Biostatistics Series (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc4024090

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) General biostatistics (92B15) Research exposition (monographs, survey articles) pertaining to statistics (62-02) Medical applications (general) (92C50) Research exposition (monographs, survey articles) pertaining to biology (92-02)

Related Items (3)

Interphase Clinical Trials: Phase III/Phase IV ⋮ The Simon’s two-stage design accounting for genetic heterogeneity ⋮ MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION

Recommendations

• Title not available (Why is that?) 👍 👎
• Two-stage design for phase II oncology trials with relaxed futility stopping 👍 👎
• Adaptive clinical trial designs for phase I cancer studies 👍 👎
• Optimal adaptive two-stage designs for phase II cancer clinical trials 👍 👎
• MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION 👍 👎
• Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials 👍 👎

This page was built for publication: Randomized phase II cancer clinical trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2852232)